1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine manufacturers
- Vonoprazan Impurity
-
-
2025-12-16
- CAS:1610043-62-3
- Min. Order: 10mg
- Purity: 98
- Supply Ability: 100000000
|
| | 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine Basic information |
| Product Name: | 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine | | Synonyms: | Vonoprazan-015;TAK438 Impurity 8;Vonoprazan impurity 19/1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine;Vonoprazan Impurity 65;Vonoprazan-21;Vonola fumarate in favor of product impurity P;5-(2-Fluorophenyl)-N-methyl-1H-pyrrole-3-methanamine;1-[5-(2-Fluorophenyl)-1H-pyrrol-3-yl]-N-methylmethylamine | | CAS: | 1610043-62-3 | | MF: | C12H13FN2 | | MW: | 204.24 | | EINECS: | | | Product Categories: | | | Mol File: | 1610043-62-3.mol |  |
| | 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine Chemical Properties |
| Boiling point | 326.5±32.0 °C(Predicted) | | density | 1.141±0.06 g/cm3(Predicted) | | solubility | DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) | | form | Sticky Solid to Solid | | pka | 16.60±0.50(Predicted) | | color | Pale Yellow to Brown | | Stability: | Hygroscopic | | InChI | InChI=1S/C12H13FN2/c1-14-7-9-6-12(15-8-9)10-4-2-3-5-11(10)13/h2-6,8,14-15H,7H2,1H3 | | InChIKey | XJZQDVQLOSFFRK-UHFFFAOYSA-N | | SMILES | N1C(C2=CC=CC=C2F)=CC(CNC)=C1 |
| | 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine Usage And Synthesis |
| Uses | 5-(2-Fluorophenyl)-N-methyl-1H-pyrrole-3-methanamine is an impurity of Vonoprazan a novel potassium-competitive acid blocker for the treatment of acid-related diseases. |
| | 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine Preparation Products And Raw materials |
|
|
Tag:1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine(1610043-62-3)
Related Product Information
|
|
5-(4-fluorophenyl)-1H-pyrrole-3-carbonitrile
1-methylpyridin-1-ium-4-sulfonate
5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde
Vonoprazan Fumarate impurity
5-chloropyridine-3-sulfonyl chloride
5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde
Pyridine-4-sulfonyl Chloride
(3S,6R,E)-6-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis
((tert-butyldimethylsilyl)oxy)cyclohexylidene)
ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-
2,3-dimethylhept-4-en-2-ol
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol
(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy-
5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-
inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
PL-A':(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy
lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
PL-AS':(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimeth
ylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept
-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one
benzyl (4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)
carbamate
tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl
-6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl)
-7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane
|